Becton, Dickinson and Company Stock
Equities
BDX
US0758871091
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
236.3 USD | -0.14% | +0.27% | -3.09% |
Financials (USD)
Sales 2024 * | 20.23B | Sales 2025 * | 21.42B | Capitalization | 68.29B |
---|---|---|---|---|---|
Net income 2024 * | 2.12B | Net income 2025 * | 2.48B | EV / Sales 2024 * | 4.03 x |
Net Debt 2024 * | 13.21B | Net Debt 2025 * | 10.71B | EV / Sales 2025 * | 3.69 x |
P/E ratio 2024 * |
32.4
x | P/E ratio 2025 * |
29.4
x | Employees | 73,000 |
Yield 2024 * |
1.59% | Yield 2025 * |
1.63% | Free-Float | 77.74% |
Latest transcript on Becton, Dickinson and Company
1 day | -0.14% | ||
1 week | +0.27% | ||
Current month | +0.72% | ||
1 month | +1.35% | ||
3 months | -1.85% | ||
6 months | +1.30% | ||
Current year | -3.09% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 50 | 08-12-31 |
Director of Finance/CFO | 52 | 21-09-05 | |
Chief Tech/Sci/R&D Officer | 48 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 73 | 02-09-23 |
Catherine Burzik
BRD | Director/Board Member | 73 | 13-01-28 |
Director/Board Member | 69 | 10-07-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
15.40% | 254 M€ | +10.97% | - | |
2.78% | 2 M€ | 0.00% | - | |
2.47% | 6 M€ | +16.84% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 236.3 | -0.14% | 1,785,047 |
24-05-16 | 236.6 | -0.28% | 1,291,452 |
24-05-15 | 237.3 | +0.97% | 1,168,003 |
24-05-14 | 235 | -0.82% | 1,049,467 |
24-05-13 | 237 | +0.54% | 1,073,151 |
Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.09% | 68.29B | |
-5.43% | 181B | |
+4.30% | 114B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B | |
-1.25% | 24.72B |
- Stock Market
- Equities
- BDX Stock